Dr. Ulrich Köstlin
Member of the Executive Board
Dr. Ulrich Köstlin is Member of the Board of Management of Bayer Schering Pharma AG and Member of the Bayer HealthCare Executive Committee. Within the combined pharmaceutical businesses of Bayer und Schering, he is responsible for the Primary Care, Women's Healthcare and Diagnostic Imaging product groups. He is also in charge of the regional business in Europe, Asia and Japan.
Career
Dr. Köstlin was born in Stuttgart, Germany, on December 31, 1952. He studied law at the University of Erlangen and the University of Tübingen in Germany and the University of Geneva in Switzerland. He holds a Dr. iur. from Tübingen University and a Master of Laws from Pennsylvania Law School.
Dr. Köstlin began his career with Schering AG in 1982 as a management trainee. He served as General Manager for several subsidiaries of Schering AG in Latin America from 1983 to 1986 and was then appointed Head of the Pharma Division for Latin America and Canada. He served as Vice President Marketing and Sales and General Manager Diagnostic Imaging of Berlex Laboratories, Inc., USA, from 1990 to 1993 and as a member of the Pharma Executive Committee of Schering AG from 1993 to 1994.
Dr. Ulrich Köstlin was appointed to the Executive Board of Schering AG in 1994, with responsibility for Marketing and Sales and Schering AG’s regional businesses.
Dr. Ulrich Köstlin is Chairman of the Supervisory Board of Bayer Vital GmbH, Leverkusen, Germany and a member of the Supervisory Board of Schering Deutschland Holding AG, Hamburg, Germany and of ALBA AG, Berlin, Germany. He is Chairman of the Board of Directors of Nihon Schering K.K., Japan and of Medrad Inc., Pittsburgh, USA and a member of the Board of Directors of Schering Oy, Finland and of ESMT GmbH, Berlin, Germany. He also is a member of the Foundation Boards of the H. Turnauer Foundation and the Arepo Foundation, both Vaduz, Liechtenstein.
